May 15, 2006 -- Combined contrast-enhanced magnetic resonance imaging (CCE MRI) is an accurate, noninvasive method for staging liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), ...
Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...
A systematic review of the effectiveness of contrast-enhanced ultrasound using SonoVue compared with contrast-enhanced CT and contrast-enhanced MRI was undertaken by the external assessment group. The ...
LINKÖPING, Sweden--(BUSINESS WIRE)--AMRA Medical has a large presence at this year’s The Liver Meeting®. A total of nine abstracts will be presented, focusing on how AMRA’s MRI-based muscle assessment ...
The diagnostics advisory committee considered evidence on MRI-based technologies for assessing non-alcoholic fatty liver disease (NAFLD) from several sources, including a diagnostics assessment report ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback